logo
Sign in

SEQUENOM INC

SAN DIEGO, X1 · Still private

Claim this profile

Follows are private to you and power your alerts

Updated

Headquarters
SAN DIEGO, X1
Latest Form D
$85M, Jun 2015
Total capital
$270M
Federal grants
$2.1M
6 awards · 1999–2001
Private capital raised
$268M
4 Form D · last Jun 2015
136 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
17
23 pending · first 2024

Capital timeline

19992003200720112015FEDERAL ↑EQUITY ↓Cumulative $270M$124K$473K$460K$453K1st Form D$1.5M
19992003200720112015FEDERAL ↑EQUITY ↓Cumulative $270M$473K$460K2nd Form D$51.6M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$85M
  • Private capital raisedForm D · SEC · 3rd filing$130M
  • Private capital raisedForm D · SEC · 2nd filing$51.6M
  • Private capital raisedForm D · SEC · 1st filing$1.5M
  • Federal grantHealth and Human S · R01 · Genome search for modifiers of severity in b thalassemia$440K
  • Federal grantHealth and Human S · R01 · Genomewide search for modifiers of severity in beta-tha*$453K
  • Federal grantHealth and Human S · R01 · Genomewide search for modifiers of severity in beta-tha*$460K
Show 3 earlier federal awards
  • Federal grantHealth and Human S · R01 · Genomewide search for modifiers of severity in beta-tha*$473K
  • Federal grantHealth and Human S · Phase I · M Tuberculosis Strain Genotyping By Mass Spectrometry$100K
  • Federal grantHealth and Human S · Phase I · Large-scale Genotyping By Chip-based Mass Spectrometry$124K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

124months

from SEQUENOM INC’s first federal award to its first private round.

First federal award · Sep 1999
Health and Human S · $124K
First Form D · Dec 2009
$1.5M · 1st Form D
Awards before first raise
6 awards

An association in public records, not a cause or a prediction.

Founders and team

Researcher links verified by same-company patents and grants
  • Charles R. CantorResearcherExecutive OfficerLinked by 1 patent
  • Alexander T. MonkoExecutive OfficerNamed in SEC Form D filings
  • Alisa T. JudgeExecutive OfficerNamed in SEC Form D filings
  • Allen T. BombardExecutive OfficerNamed in SEC Form D filings
  • Carolyn F. BeaverExecutive OfficerNamed in SEC Form D filings
  • Charles M. SlacikDirectorNamed in SEC Form D filings
Show all 25 people
  • Clarke T. NeumannExecutive OfficerNamed in SEC Form D filings
  • Daniel S. GrosuExecutive OfficerNamed in SEC Form D filings
  • David M. PendarvisDirectorNamed in SEC Form D filings
  • Dirk T. van den BoomExecutive OfficerNamed in SEC Form D filings
  • Ernst-Gunter F. AftingDirectorNamed in SEC Form D filings
  • Gary T. RiordanExecutive OfficerNamed in SEC Form D filings
  • Harry F. HixsonExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeff M. LintonExecutive OfficerNamed in SEC Form D filings
  • John A. FazioDirectorNamed in SEC Form D filings
  • Kathleen W. WiltseyDirectorNamed in SEC Form D filings
  • Kenneth F. BuechlerDirectorNamed in SEC Form D filings
  • Larry T. MyresExecutive OfficerNamed in SEC Form D filings
  • Myla S. Lai-GoldmanDirectorNamed in SEC Form D filings
  • Paul M. MaierExecutive OfficerNamed in SEC Form D filings
  • Richard A. LernerDirectorNamed in SEC Form D filings
  • Robin S. WeinerExecutive OfficerNamed in SEC Form D filings
  • Ronald M. LindsayExecutive Officer, DirectorNamed in SEC Form D filings
  • Shawn T. MarcellExecutive OfficerNamed in SEC Form D filings
  • William T. WelchExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 17 granted of 40
Show all 40 patent records

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .